Alba Vidal-Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alba Vidal-Torres has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Begoña Fernández-Pastor
WeLab Barcelona, Parc Científic de Barcelona, Barcelona 08028, Spain
4 shared publications- José Miguel Vela
Autonomous University of Barcelona
4 shared publications - Manuel Merlos
Drug Development and Clinical Research, Palau Pharma, Barcelona, Spain
4 shared publications Alicia Carceller
Drug Discovery and Preclinical Development, Esteve Pharmaceuticals, Parc Científic Barcelona, Barcelona, Spain
3 shared publications- Daniel Zamanillo
WeLab Barcelona, Parc Científic de Barcelona, Barcelona 08028, Spain
2 shared publications - Luz Romero
Drug Discovery and Preclinical Development, ESTEVE, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 1 September 2024
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 24 (17) , 654-670
Evaluation of road roughness and its influence on operating parameters in open-pit mines
Hauling ore and waste rock is a major cost factor in open-pit mines, encompassing both road maintenance and off-road truck operation. Road maintenance costs are directly influenced by traffic volume and the size of trucks using the roads. Off-road truck operating costs are impacted by various factors, including those affecting their movement, such as the direct interaction between tires and the road surface. Tire-road interaction significantly affects rolling resistance. Rougher surfaces with deeper grooves caused by track sinks lead to higher rolling resistance. This study employed laser profiling to characterize the surface roughness of five mine haul roads in two large Brazilian iron ore mines. This study evaluated the impact of these road irregularities on various operating parameters for 240-ton off-highway trucks, including rolling resistance, average travel speed, travel time, productivity, and unit transport cost. The results indicate that a 10 cm increase in road surface roughness can lead to a significant increase in rolling resistance (up to 5%), a substantial decrease in average speed (25%), a notable increase in travel time (26%), a decrease in productivity (19%), and a corresponding increase in unit transport cost (21%).
- 1 September 2024
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 24 (17) , 654-670
Open AccessEvaluation of road roughness and its influence on operating parameters in open-pit mines
Hauling ore and waste rock is a major cost factor in open-pit mines, encompassing both road maintenance and off-road truck operation. Road maintenance costs are directly influenced by traffic volume and the size of trucks using the roads. Off-road truck operating costs are impacted by various factors, including those affecting their movement, such as the direct interaction between tires and the road surface. Tire-road interaction significantly affects rolling resistance. Rougher surfaces with deeper grooves caused by track sinks lead to higher rolling resistance. This study employed laser profiling to characterize the surface roughness of five mine haul roads in two large Brazilian iron ore mines. This study evaluated the impact of these road irregularities on various operating parameters for 240-ton off-highway trucks, including rolling resistance, average travel speed, travel time, productivity, and unit transport cost. The results indicate that a 10 cm increase in road surface roughness can lead to a significant increase in rolling resistance (up to 5%), a substantial decrease in average speed (25%), a notable increase in travel time (26%), a decrease in productivity (19%), and a corresponding increase in unit transport cost (21%).
- Open Access
- 25 September 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (1) , 82-99
Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
- 25 September 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (1) , 82-99
Open AccessBispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
- Open Access
- 24 April 2019
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 422
Supraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception
Sigma-1 receptor (σ1R) antagonism increases the effects of morphine on acute nociceptive pain. S1RA (E-52862) is a selective σ1R antagonist widely used to study the role of σ1Rs. S1RA alone exerted antinociceptive effect in the formalin test in rats and increased noradrenaline levels in the spinal cord, thus accounting for its antinociceptive effect. Conversely, while systemic S1RA failed to elicit antinociceptive effect by itself in the tail-flick test in mice, it did potentiate the antinociceptive effect of opioids in this acute pain model. The present study aimed to investigate the site of action and the involvement of spinal noradrenaline on the potentiation of opioid antinociception by S1RA on acute thermal nociception using the tail-flick test in rats. Local administration was performed after intrathecal catheterization or intracerebroventricular and rostroventral medullar (RVM) cannulae implantation. Noradrenaline levels in the spinal cord were evaluated using the concentric microdialysis technique in awake, freely-moving rats. Systemic or supraspinal administration of S1RA alone, while having no effect on antinociception, enhanced the effect of morphine in rats. However, spinal S1RA administration did not potentiate the antinociceptive effect of morphine. Additionally, the peripherally restricted opioid agonist loperamide was devoid of antinociceptive effect but produced antinociception when combined with S1RA. Neurochemical studies revealed that noradrenaline levels in the dorsal horn of the spinal cord were not increased at doses exerting potentiation of the antinociceptive effect of the opioid. In conclusion, the site of action of σ1R for opioid modulation on acute thermal nociception is located at the peripheral and supraspinal levels, and the opioid-potentiating effect is independent of the spinal noradrenaline increase produced by S1RA.
- 24 April 2019
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 422
Open AccessSupraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception
Sigma-1 receptor (σ1R) antagonism increases the effects of morphine on acute nociceptive pain. S1RA (E-52862) is a selective σ1R antagonist widely used to study the role of σ1Rs. S1RA alone exerted antinociceptive effect in the formalin test in rats and increased noradrenaline levels in the spinal cord, thus accounting for its antinociceptive effect. Conversely, while systemic S1RA failed to elicit antinociceptive effect by itself in the tail-flick test in mice, it did potentiate the antinociceptive effect of opioids in this acute pain model. The present study aimed to investigate the site of action and the involvement of spinal noradrenaline on the potentiation of opioid antinociception by S1RA on acute thermal nociception using the tail-flick test in rats. Local administration was performed after intrathecal catheterization or intracerebroventricular and rostroventral medullar (RVM) cannulae implantation. Noradrenaline levels in the spinal cord were evaluated using the concentric microdialysis technique in awake, freely-moving rats. Systemic or supraspinal administration of S1RA alone, while having no effect on antinociception, enhanced the effect of morphine in rats. However, spinal S1RA administration did not potentiate the antinociceptive effect of morphine. Additionally, the peripherally restricted opioid agonist loperamide was devoid of antinociceptive effect but produced antinociception when combined with S1RA. Neurochemical studies revealed that noradrenaline levels in the dorsal horn of the spinal cord were not increased at doses exerting potentiation of the antinociceptive effect of the opioid. In conclusion, the site of action of σ1R for opioid modulation on acute thermal nociception is located at the peripheral and supraspinal levels, and the opioid-potentiating effect is independent of the spinal noradrenaline increase produced by S1RA.
- 29 January 2014
- Published by Wiley in Journal of Neurochemistry
- Vol. 129 (3) , 484-494
Effects of the selective sigma‐1 receptor antagonist S1RAon formalin‐induced pain behavior and neurotransmitter release in the spinal cord in rats
We have previously shown that the selective sigma‐1 receptor (σ1R) antagonist S1RA(E‐52862) inhibits neuropathic pain and activity‐induced spinal sensitization in various pre‐clinical pain models. In this study we characterized both the behavioral and the spinal neurochemical effects of S1RAin the rat formalin test. Systemic administration of S1RAproduced a dose‐related attenuation of flinching and lifting/licking behaviors in the formalin test. Neurochemical studies using concentric microdialysis in the ipsilateral dorsal horn of awake, freely moving rats revealed that the systemic S1RA‐induced antinociceptive effect occurs concomitantly with an enhancement of noradrenaline levels and an attenuation of formalin‐evoked glutamate release in the spinal dorsal horn. Intrathecal pre‐treatment with idazoxan prevented the systemic S1RAantinociceptive effect, suggesting that the S1RAantinociception depends on the activation of spinal α2‐adrenoceptors which, in turn, could induce an inhibition of formalin‐evoked glutamate release. When administered locally, intrathecal S1RAinhibited only the flinching behavior, whereas intracerebroventricularly or intraplantarly injected also attenuated the lifting/licking behavior. These results suggest that S1RAsupraspinally activates the descending noradrenergic pain inhibitory system, which may explain part of its antinociceptive properties in the formalin test; however, effects at other central and peripheral sites also account for the overall effect. image Formalin‐induced nociceptive effect occurs concomitantly with an enhancement of glutamate (Glu) level in the dorsal horn spinal cord. The selective σ1 receptor antagonist S1RA results in inhibition of formalin‐evoked Glu release, no modification of GABA levels, and enhancement of noradrenaline (NA) levels. This increased spinal NA activates spinal α2‐adrenoceptors producing the attenuation of the formalin‐induced pain behaviour
- 29 January 2014
- Published by Wiley in Journal of Neurochemistry
- Vol. 129 (3) , 484-494
Effects of the selective sigma‐1 receptor antagonist S1RAon formalin‐induced pain behavior and neurotransmitter release in the spinal cord in rats
We have previously shown that the selective sigma‐1 receptor (σ1R) antagonist S1RA(E‐52862) inhibits neuropathic pain and activity‐induced spinal sensitization in various pre‐clinical pain models. In this study we characterized both the behavioral and the spinal neurochemical effects of S1RAin the rat formalin test. Systemic administration of S1RAproduced a dose‐related attenuation of flinching and lifting/licking behaviors in the formalin test. Neurochemical studies using concentric microdialysis in the ipsilateral dorsal horn of awake, freely moving rats revealed that the systemic S1RA‐induced antinociceptive effect occurs concomitantly with an enhancement of noradrenaline levels and an attenuation of formalin‐evoked glutamate release in the spinal dorsal horn. Intrathecal pre‐treatment with idazoxan prevented the systemic S1RAantinociceptive effect, suggesting that the S1RAantinociception depends on the activation of spinal α2‐adrenoceptors which, in turn, could induce an inhibition of formalin‐evoked glutamate release. When administered locally, intrathecal S1RAinhibited only the flinching behavior, whereas intracerebroventricularly or intraplantarly injected also attenuated the lifting/licking behavior. These results suggest that S1RAsupraspinally activates the descending noradrenergic pain inhibitory system, which may explain part of its antinociceptive properties in the formalin test; however, effects at other central and peripheral sites also account for the overall effect. image Formalin‐induced nociceptive effect occurs concomitantly with an enhancement of glutamate (Glu) level in the dorsal horn spinal cord. The selective σ1 receptor antagonist S1RA results in inhibition of formalin‐evoked Glu release, no modification of GABA levels, and enhancement of noradrenaline (NA) levels. This increased spinal NA activates spinal α2‐adrenoceptors producing the attenuation of the formalin‐induced pain behaviour
- 1 July 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 711 (1-3) , 63-72
Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects
- 1 July 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 711 (1-3) , 63-72
Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects
- 1 January 2012
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 120 (2) , 129-132
Evaluation of Formalin-Induced Pain Behavior and Glutamate Release in the Spinal Dorsal Horn Using In Vivo Microdialysis in Conscious Rats
Measurement of neurotransmitters in the spinal dorsal horn in conscious animals remains a technical challenge. Here we applied concentric microdialysis to measure formalin-induced glutamate (Glu) release in the ipsilateral dorsal horn in conscious, freely-moving rats. Hind paw formalin injection induced flinching nociceptive behaviors accompanied by increased Glu in the dorsal horn (maximum = 294%). Both flinching and Glu increase were prevented by morphine (3 mg/kg, s.c.). Accordingly, concentric microdialysis is a sensitive technique for studying neurochemical modulation induced by pain and analgesics in the spinal dorsal horn of awake rats. Measurement of Glu provides information on modulation of excitatory signals.
- 1 January 2012
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 120 (2) , 129-132
Evaluation of Formalin-Induced Pain Behavior and Glutamate Release in the Spinal Dorsal Horn Using In Vivo Microdialysis in Conscious Rats
Measurement of neurotransmitters in the spinal dorsal horn in conscious animals remains a technical challenge. Here we applied concentric microdialysis to measure formalin-induced glutamate (Glu) release in the ipsilateral dorsal horn in conscious, freely-moving rats. Hind paw formalin injection induced flinching nociceptive behaviors accompanied by increased Glu in the dorsal horn (maximum = 294%). Both flinching and Glu increase were prevented by morphine (3 mg/kg, s.c.). Accordingly, concentric microdialysis is a sensitive technique for studying neurochemical modulation induced by pain and analgesics in the spinal dorsal horn of awake rats. Measurement of Glu provides information on modulation of excitatory signals.